Académique Documents
Professionnel Documents
Culture Documents
RHU DRUG U
Fo
M
A
I Source of Balance of
Procurement / Last Month
N Health Program Name of Medicines & Description No. of Target
Funds ei. DOH- Patients
T CO/DOH-RO Delivery Date
E
N
A
N
C (a)
E
Amlodipine 10mg, 30 tablets / treatment
M CO 1 pack (TP) 388 377 2/26/2018
E
D
I Losartan 50mg, 30 tablets / treatment
CO 2
pack (TP) 329 1 2/26/2018
C
I
N CO 3 Metoprolol 50mg, 60 tablets / treatment
E pack (TP)
43 24
S
Metformin 500mg, 90 tablets / treatment
A CO 4 pack (TP)
C 62 15 2/26/2018
C Simvastatin 40mg, 30 tablets / treatment
E CO 5 pack (TP)
SF 0 2/26/2018
AS
M CO 6 Gliclazide
PI 0
RL
Y
O Combined Oral Contraceptive Pills (COC)
G per cycle - Microgynon
P 396 2/17/2018
R 1
A L Combined Oral Contraceptive Pills (COC)
A
M per cycle - Femme
N 45
N(
M I
N
M
G)
2
P
L
A
N
N Progestin Only Pills (POP) per cycle -
I 2
Excluton
N 105 2/17/2018
G
Depo medroxyprogesterone acetate
3
(DMPA) vial
P 334
R
O 4 Intrauterine Device (IUD)
G 9 2-2018
R
A 5 Male Condoms
M 55
(
F
P
)
3
Source of Balance of
Procurement / No. of Target Last Month
Health Program Name of Medicines & Description
Funds ei. DOH- Patients
E CO/DOH-RO
Delivery Date
X
P
A
N (a)
D
1 Bivalent Oral Polio Vaccine (BOPV)
E 52 2/26/2018
D
2 Inactivated Polio Vaccine (IPV)
33 2/26/2018
P
R 3 BCG Vaccine, 20 doses
42
O
G 4 Hepatitis B vaccine, 10 doses 20
R
A Live attenuated measles, mumps, rubella
5 multidose (MMR) 113 2/26/2018
M
6 MR vaccine, 10 doses
F 29
O
R 7 DPT-HEPB-HIB vaccine 0.5ml (Penta)
231 2/26/2018
I 8 TD vaccine, single dose
240
M
M 9 TD vaccine, 10 doses
0
U
N 10 HPV vaccine 4-valent
I 88
Z 11 Pneumococcal Conjugate Vaccine
A (PCV 13) 332 2/26/2018
T
12 Polysaccharide
I Polyvalent Vaccine (PPV
23) 0
O
N 13 Influenza Vaccine
0
( Vitamin A 100,000 iu, 100 tablets per
E 1 bottle 7
P
NI 2 Vitamin A 200,000 iu, 100 tablets per
U) bottle 32
T
R 3 FeSO4 drops 125mg
I 161
T 4 Iron tablet with Folic acid, 100 tablets per
I bottle 1584
O
Micronutrient powder, sachets
N - Sprinkles 0
5
P Micronutrient powder, sachets
R - Vitamix 6531
O
G 6 Iodine capsules
R 0
A
M 7 Iodine salt test kits
0
O 4
G
R
A
M
Source of Balance of
Procurement / No. of Target Last Month
Health Program Name of Medicines & Description
Funds ei. DOH- Patients
CO/DOH-RO
Delivery Date
(a)
Prepared by:
LOVELY LYN P. ANO-OS / IRIS L. EMPASIS
Logistics Coordinator/Medicines Access Program Coordinator
7
Beginning
Stocks of the
Total Month
Total Cost
Discrepancy
Qty. stated Qty. Received
in the from Other Actual Qty.
Health Facility Unit (tab, Unit Cost
Invoice (other than Received amp, cap,
Receipt Expiry Date Lot No.
DOH), if any pcs, pack
e = b - d OR etc.)
g=dxf h=a+c+d
e=c-d
TP 0 24
TP 0 0
per cycle 0 45
8
vial 0 334
box by 3's 0 55
9
27 27 0 9-2019 vial 0 60
vial 0 42
vial 0 20
vial
42 42 0 8-2018 0 155
vial
0 29
vial
714 714 0 5-2019 0 945
amp 0 240
vial 0 0
vial 0 88
vial
560 560 0 3-2020 0 892
vial
0 0
vial 0 0
bottle
0 7
bottle
0 32
bottle
0 161
bottle
0 1584
sachet
0 0
sachet
0 6531
per bottle
0 0
per kit
0 0
10
6/15/201 sachet
2700 2700 8 2416 0 2700
vial
0 0
vial
0 0
vial
0 5
bottle
0 500
0 0
11
tab 0 0
tab 0 0
tab
0 0
tab
0 0
tab 0 0
tab 0 0
tab 0 0
tab 0 0
tab 0 0
vial 0 0
vial 0 0
amp 0 0
tab 0 0
tab 0 0
amp 0 0
amp
0 0
tab 0 0
tab 0 0
tab 0 0
tab 0 0
tab 0 0
tab
0 0
tab 0 0
tab 0 0
12
cap 0 0
tab 0 0
Number of DOH
Medicines Dispensed
8 8 0 16
58 58 1437.82 557
4 4 146.68 96
0 0 0
0 0 45
14
40 40 0 83
39 39 0 295
2 2 0 18
23 23 0 32
15
Number of DOH
Medicines Dispensed
Qty. End of the
Qty. of Total Cost
Dispensed Qty. of Month
Medicines
Expired
Transferred/ Medicines
Beneficiaries Non- Donated
Beneficiaries
n = (k + l + o = h - (k + l
k=i+j m) x f + m)
8 8 0 98
7 7 0 53
7 7 0 35
0 0 20
24 24 0 131
0 0 29
0 0 0
0 0 88
0 0 0
0 0 0
1 1 0 6
3 3 0 29
30 30 0 131
37 37 0 1547
0 0 0
0 0 0
0 0 0
16
0 0 0
0 0 0
0 0 5
7 7 0 493
0 0 0
17
Number of DOH
Medicines Dispensed
Qty. Qty. of End of the
Qty. of Total Cost
Dispensed Medicines Month
Expired
Transferred/ Medicines
Beneficiaries Non- Donated
Beneficiaries
n = (k + l + o = h - (k + l
k=i+j m) x f + m)
(i) (j) (k) (l) (m) (n) (o)
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
18
0 0 0
0 0 0
lidated by:
RHU DRUG
F
M
A
I Source of Balance of
Procurement / Last Month
N Health Program Name of Medicines & Description No. of Target
Funds ei. DOH- Patients
T CO/DOH-RO Delivery Date
E
N
A
N
C (a)
E
Amlodipine 10mg, 30 tablets / treatment
M CO 1 pack (TP) 388 2100
E
D
I Losartan 50mg, 30 tablets / treatment
CO 2
pack (TP) 329 850
C
I
N CO 3 Metoprolol 50mg, 60 tablets / treatment
E pack (TP)
43 16
S
Metformin 500mg, 90 tablets / treatment
A CO 4 pack (TP)
C 62 557
C Simvastatin 40mg, 30 tablets / treatment
E CO 5 pack (TP)
SF 30 96
AS
M CO 6 Gliclazide
PI 10 0
RL
Y
O Combined Oral Contraceptive Pills (COC)
G per cycle - Microgynon
P 934 362
R 1
A L Combined Oral Contraceptive Pills (COC)
A
M per cycle - Femme
N 401 45
N(
M I
N
M
G)
20
P
L
A
N
N Progestin Only Pills (POP) per cycle -
I 2
Excluton
N 171 83
G
Depo medroxyprogesterone acetate
3
(DMPA) vial
P 183 295
R
O 4 Intrauterine Device (IUD)
G 25 18
R
A 5 Male Condoms
M 97 32
(
F
P
)
21
Source of Balance of
Procurement / No. of Target Last Month
Health Program Name of Medicines & Description
Funds ei. DOH- Patients
E CO/DOH-RO
Delivery Date
X
P
A
N (a)
D
1 Bivalent Oral Polio Vaccine (BOPV)
E 148 98
D
2 Inactivated Polio Vaccine (IPV)
42 53
P
R 3 BCG Vaccine, 20 doses
50 35
O
G 4 Hepatitis B vaccine, 10 doses 10 20
R
A Live attenuated measles, mumps, rubella
5 multidose (MMR) 80 131
M
6 MR vaccine, 10 doses
F 10 29
O
R 7 DPT-HEPB-HIB vaccine 0.5ml (Penta)
160 794
I 8 TD vaccine, single dose
50 139
M
M 9 TD vaccine, 10 doses
0 0
U
N 10 HPV vaccine 4-valent
I 50 88
Z 11 Pneumococcal Conjugate Vaccine
A (PCV 13) 200 676
T
12 Polysaccharide
I Polyvalent Vaccine (PPV
23) 0 0
O
N 13 Influenza Vaccine
0 0
( Vitamin A 100,000 iu, 100 tablets per
E 1 bottle 50 6
P
NI 2 Vitamin A 200,000 iu, 100 tablets per
U) bottle 50 29
T
R 3 FeSO4 drops 125mg
I 25 131
T 4 Iron tablet with Folic acid, 100 tablets per
I bottle 50 1547
O
Micronutrient powder, sachets
N - Sprinkles 0 0
5
P Micronutrient powder, sachets
R - Vitamix 30 4991
O
G 6 Iodine capsules
R 0 0
A
M 7 Iodine salt test kits
0 0
O 22
G
R
A
M
Source of Balance of
Procurement / No. of Target Last Month
Health Program Name of Medicines & Description
Funds ei. DOH- Patients
CO/DOH-RO
Delivery Date
(a)
Prepared by:
LOVELY LYN P. ANO-OS / IRIS L. EMPASIS
Logistics Coordinator/Medicines Access Program Coordinator
25
Beginning
Stocks of the
Total Month
Total Cost
Discrepancy
Qty. Received
Qty. stated in from Other Actual Qty. Unit (tab,
the Invoice Health Facility Unit Cost
(other than Received amp, cap,
Receipt Expiry Date Lot No.
DOH), if any pcs, pack
e = b - d OR etc.)
g=dxf h=a+c+d
e=c-d
TP 2100
TP 850
TP 0 16
TP 0 557
TP 0 96
TP 0 0
per cycle 0 45
26
per cycle 0 83
vial 0 295
per device 0 18
box by 3's 0 32
27
0 vial 0 98
0 vial 0 53
vial 0 35
vial 0 20
vial
0 131
vial
0 29
vial
0 794
amp 0 139
vial 0 0
vial 0 88
vial
0 676
vial
0 0
vial 0 0
bottle
0 6
bottle
0 29
bottle
0 131
bottle
0 1547
sachet
0 0
sachet
0 4991
per bottle
0 0
per kit
0 0
28
6/15/201 sachet
2700 2700 0 0 8 2416 0 5255
vial
0 0
vial
0 0
vial
0 5
bottle
0 493
0 0
29
tab 0 0
tab 0 0
tab
0 0
tab
0 0
tab 0 0
tab 0 0
tab 0 0
tab 0 0
tab 0 0
vial 0 0
vial 0 0
amp 0 0
tab 0 0
tab 0 0
amp 0 0
amp
0 0
tab 0 0
tab 0 0
tab 0 0
tab 0 0
tab 0 0
tab
0 0
tab 0 0
tab 0 0
30
cap 0 0
tab 0 0
Number of DOH
Medicines Dispensed
4 4 0 12
13 13 0 544
15 15 0 81
0 0 0 0
8 8 0 37
32
25 25 0 58
54 54 0 241
1 1 0 17
0 0 0 32
33
Number of DOH
Medicines Dispensed
Qty. End of the
Qty. of Total Cost
Dispensed Qty. of Month
Medicines
Expired
Transferred/ Medicines
Beneficiaries Non- Donated
Beneficiaries
n = (k + l + o = h - (k + l
k=i+j m) x f + m)
9 9 0 89
5 5 0 48
7 7 0 28
0 0 0 20
20 20 0 111
0 0 0 29
70 70 0 69
0 0 0 0
0 0 0 88
0 0 0 0
0 0 0 0
0 0 0 6
0 0 0 29
0 0 0 131
0 0 0 1547
0 0 0
0 0 0 4991
0 0 0
0 0 0
34
0 0 0
0 0 0
1 1 0 4
37 37 0 456
0 0 0
35
Number of DOH
Medicines Dispensed
Qty. Qty. of End of the
Qty. of Total Cost
Dispensed Medicines Month
Expired
Transferred/ Medicines
Beneficiaries Non- Donated
Beneficiaries
n = (k + l + o = h - (k + l
k=i+j m) x f + m)
(i) (j) (k) (l) (m) (n) (o)
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
36
0 0 0
0 0 0
lidated by:
RHU DRUG
F
M
A
I Source of Balance of
Procurement / Last Month
N Health Program Name of Medicines & Description No. of Target
Funds ei. DOH- Patients
T CO/DOH-RO Delivery Date
E
N
A
N
C (a)
E
Amlodipine 10mg, 30 tablets / treatment
M CO 1 pack (TP) 388 1893
E
D
I Losartan 50mg, 30 tablets / treatment
CO 2
pack (TP) 329 715
C
I
N CO 3 Metoprolol 50mg, 60 tablets / treatment
E pack (TP)
43 12
S
Metformin 500mg, 90 tablets / treatment
A CO 4 pack (TP)
C 62 544
C Simvastatin 40mg, 30 tablets / treatment
E CO 5 pack (TP)
SF 30 81
AS
M CO 6 Gliclazide
PI 10 0
RL
Y
O Combined Oral Contraceptive Pills (COC)
G per cycle - Microgynon
P 934 128 5/4/2018
R 1
A L Combined Oral Contraceptive Pills (COC)
A
M per cycle - Femme
N 401 37
N(
M I
N
M
G)
38
P
L
A
N
N Progestin Only Pills (POP) per cycle -
I 2
Excluton
N 171 58 4/27/2018
G
Depo medroxyprogesterone acetate
3
(DMPA) vial
P 183 241
R
O 4 Intrauterine Device (IUD)
G 25 17
R
A 5 Male Condoms
M 97 32 4/27/2018
(
F
P
)
39
Source of Balance of
Procurement / No. of Target Last Month
Health Program Name of Medicines & Description
Funds ei. DOH- Patients
E CO/DOH-RO
Delivery Date
X
P
A
N (a)
D
1 Bivalent Oral Polio Vaccine (BOPV)
E 148 89
D
2 Inactivated Polio Vaccine (IPV)
42 48 4/13/2018
P
R 3 BCG Vaccine, 20 doses
50 28
O
G 4 Hepatitis B vaccine, 10 doses 10 20
R
A Live attenuated measles, mumps, rubella
5 multidose (MMR) 80 111 4/13/2018
M
6 MR vaccine, 10 doses
F 10 29
O
R 7 DPT-HEPB-HIB vaccine 0.5ml (Penta)
160 677
I 8 TD vaccine, single dose
50 69
M
M 9 TD vaccine, 10 doses
0 0 4/13/2018
U
N 10 HPV vaccine 4-valent
I 50 88
Z 11 Pneumococcal Conjugate Vaccine
A (PCV 13) 200 495 4/13/2018
T
12 Polysaccharide
I Polyvalent Vaccine (PPV
23) 0 0
O
N 13 Influenza Vaccine
0 0
( Vitamin A 100,000 iu, 100 tablets per
E 1 bottle 50 6
P
NI 2 Vitamin A 200,000 iu, 100 tablets per
U) bottle 50 29 Apr-18
T
R 3 FeSO4 drops 125mg
I 25 131
T 4 Iron tablet with Folic acid, 100 tablets per
I bottle 50 1547
O
Micronutrient powder, sachets
N - Sprinkles 0 0
5
P Micronutrient powder, sachets
R - Vitamix 30 4991
O
G 6 Iodine capsules
R 0 0
A
M 7 Iodine salt test kits
0 0
O 40
G
R
A
M
Source of Balance of
Procurement / No. of Target Last Month
Health Program Name of Medicines & Description
Funds ei. DOH- Patients
CO/DOH-RO
Delivery Date
(a)
Prepared by:
LOVELY LYN P. ANO-OS / IRIS L. EMPASIS
Logistics Coordinator/Medicines Access Program Coordinator
43
Beginning
Stocks of the
Total Month
Total Cost
Discrepancy
Qty. Received
Qty. stated in from Other Actual Qty. Unit (tab,
the Invoice Health Facility Unit Cost
(other than Received amp, cap,
Receipt Expiry Date Lot No.
DOH), if any pcs, pack
e = b - d OR etc.)
g=dxf h=a+c+d
e=c-d
TP 1893
TP 715
TP 0 12
TP 0 544
TP 0 81
TP 0 0
per cycle 0 37
44
vial 0 241
per device 0 17
box by 3's 0 80
48 48 7-2020 L44028
45
vial 0 89
14 14 9-2019 vial 0 62
vial 0 28
vial 0 20
vial
60 60 8-2018 0 171
vial
0 29
vial
0 677
amp 0 69
24 24 6-2019 vial 0 24
vial 0 88
vial
252 252 3-2020 0 747
vial
0 0
vial 0 0
bottle
0 6
bottle
48 0 48 0 77
bottle
0 131
bottle
0 1547
sachet
0 0
sachet
0 4991
per bottle
0 0
per kit
0 0
46
sachet
0 4955
vial
0 0
vial
0 0
vial
0 4
bottle
0 456
47
cap 0 0
tab 0 0
Number of DOH
Medicines Dispensed
12 12 0 0
80 80 0 464
5 5 0 76
0 0 0 0
0 0 0 37
50
31 31 0 103
29 29 0 212
1 1 0 16
21 21 0 59
51
Number of DOH
Medicines Dispensed
Qty. End of the
Qty. of Total Cost
Dispensed Qty. of Month
Medicines
Expired
Transferred/ Medicines
Beneficiaries Non- Donated
Beneficiaries
n = (k + l + o = h - (k + l
k=i+j m) x f + m)
13 13 0 76
8 8 0 54
9 9 0 19
0 0 0 20
39 39 0 132
0 0 0 29
41 41 0 28
10 10 0 14
0 0 0 88
29 29 0 718
0 0 0 0
0 0 0 0
0 0 0 6
22 22 0 55
43 43 0 88
0 0 0 0
0 0 0 0
0 0 0 0
52
0 0 0 0
1 1 0 3
4 4 0 452
53
Number of DOH
Medicines Dispensed
Qty. Qty. of End of the
Qty. of Total Cost
Dispensed Medicines Month
Expired
Transferred/ Medicines
Beneficiaries Non- Donated
Beneficiaries
n = (k + l + o = h - (k + l
k=i+j m) x f + m)
(i) (j) (k) (l) (m) (n) (o)
0 0 100
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 100
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 150
0 0 0
0 0 0
0 0 0
0 0 100
0 0 0
0 0 0
0 0 0
54
0 0 0
0 0 0
lidated by:
RHU DRUG
F
M
A
I Source of Balance of
Procurement / Last Month
N Health Program Name of Medicines & Description No. of Target
Funds ei. DOH- Patients
T CO/DOH-RO Delivery Date
E
N
A
N
C (a)
E
Amlodipine 10mg, 30 tablets / treatment
M CO 1 pack (TP) 397 1682 6/11/2018
E
D
I Losartan 50mg, 30 tablets / treatment
CO 2
pack (TP) 338 509 6/11/2018
C
I
N CO 3 Metoprolol 50mg, 60 tablets / treatment
E pack (TP)
43 0
S
Metformin 500mg, 90 tablets / treatment
A CO 4 pack (TP)
C 64 464 6/11/2018
C Simvastatin 40mg, 30 tablets / treatment
E CO 5 pack (TP)
SF 30 76
AS
M CO 6 Gliclazide
PI 10 0
RL
Y
O Combined Oral Contraceptive Pills (COC)
G per cycle - Microgynon
P 934 202
R 1
A L Combined Oral Contraceptive Pills (COC)
A
M per cycle - Femme
N 401 37
N(
M I
N
M
G)
56
P
L
A
N
N Progestin Only Pills (POP) per cycle -
I 2
Excluton
N 171 103
G
Depo medroxyprogesterone acetate
3
(DMPA) vial
P 183 212
R
O 4 Intrauterine Device (IUD)
G 25 16
R
A 5 Male Condoms
M 97 59
(
F
P
)
57
Source of Balance of
Procurement / No. of Target Last Month
Health Program Name of Medicines & Description
Funds ei. DOH- Patients
E CO/DOH-RO
Delivery Date
X
P
A
N (a)
D
1 Bivalent Oral Polio Vaccine (BOPV)
E 148 76
D
2 Inactivated Polio Vaccine (IPV)
42 54
P
R 3 BCG Vaccine, 20 doses
50 19
O
G 4 Hepatitis B vaccine, 10 doses 10 20
R
A Live attenuated measles, mumps, rubella
5 multidose (MMR) 80 132
M
6 MR vaccine, 10 doses
F 10 29
O
R 7 DPT-HEPB-HIB vaccine 0.5ml (Penta)
160 386
I 8 TD vaccine, single dose
50 28
M
M 9 TD vaccine, 10 doses
0 14
U
N 10 HPV vaccine 4-valent
I 50 88
Z 11 Pneumococcal Conjugate Vaccine
A (PCV 13) 200 718 6/8/2018
T
12 Polysaccharide
I Polyvalent Vaccine (PPV
23) 0 0
O
N 13 Influenza Vaccine
0 0
( Vitamin A 100,000 iu, 100 tablets per
E 1 bottle 50 6
P
NI 2 Vitamin A 200,000 iu, 100 tablets per
U) bottle 50 55
T
R 3 FeSO4 drops 125mg
I 25 88
T 4 Iron tablet with Folic acid, 100 tablets per
I bottle 50 1256
O
Micronutrient powder, sachets
N - Sprinkles 0 0
5
P Micronutrient powder, sachets
R - Vitamix 30 3155
O
G 6 Iodine capsules
R 0 0
A
M 7 Iodine salt test kits
0 0
O 58
G
R
A
M
Source of Balance of
Procurement / No. of Target Last Month
Health Program Name of Medicines & Description
Funds ei. DOH- Patients
CO/DOH-RO
Delivery Date
(a)
Prepared by:
LOVELY LYN P. ANO-OS / IRIS L. EMPASIS
Logistics Coordinator/Medicines Access Program Coordinator
61
Beginning
Stocks of the
Total Month
Total Cost
Discrepancy
Qty. Received
Qty. stated in from Other Actual Qty. Unit (tab,
the Invoice Health Facility Unit Cost
(other than Received amp, cap,
Receipt Expiry Date Lot No.
DOH), if any pcs, pack
e = b - d OR etc.)
g=dxf h=a+c+d
e=c-d
TP 0 0
TP 0 514
50 50 4-2019 M-01407
TP 0 76
TP 0 0
per cycle 0 37
62
vial 0 212
per device 0 16
box by 3's 0 59
63
vial 0 76
vial 0 54
vial 0 19
vial 0 20
vial
0 132
vial
0 29
vial
0 386
amp 0 28
vial 0 14
vial 0 88
vial
20 20 3-20202 T28219 0 738
vial
0 0
vial 0 0
bottle
0 6
bottle
0 55
bottle
0 88
bottle
0 1256
sachet
0 0
sachet
0 3155
per bottle
0 0
per kit
0 0
64
sachet
0 2646
vial
0 0
vial
0 0
vial
0 3
bottle
0 452
65
tab 0 100
tab 0 0
tab
0 0
tab
0 0
tab 0 0
tab 0 0
tab 0 100
tab 0 0
tab 0 0
vial 0 0
vial 0 0
amp 0 0
tab 0 0
tab 0 0
amp 0 0
amp
0 0
tab 0 150
tab 0 0
tab 0 0
tab 0 0
tab 0 100
tab
0 0
tab 0 0
tab 0 0
66
cap 0 0
tab 0 0
Number of DOH
Medicines Dispensed
0 0 0 0
21 21 0 493
6 6 0 70
0 0 0 0
95 95 0 107
2 2 0 35
68
38 38 0 65
30 30 0 182
2 2 0 14
14 14 0 45
69
Number of DOH
Medicines Dispensed
Qty. End of the
Qty. of Total Cost
Dispensed Qty. of Month
Medicines
Expired
Transferred/ Medicines
Beneficiaries Non- Donated
Beneficiaries
n = (k + l + o = h - (k + l
k=i+j m) x f + m)
14 14 0 62
0 0 0 54
6 6 0 13
0 0 10 0 10
13 13 0 119
0 0 0 29
48 48 0 338
6 6 0 22
6 6 0 8
0 0 0 88
0 0 0 0
0 0 0 0
0 0 0 6
12 12 0 43
35 35 0 53
47 47 0 1209
0 0 0 0
0 0 0 0
0 0 0 0
70
0 0 0 0
0 0 0 3
Number of DOH
Medicines Dispensed
Qty. Qty. of End of the
Qty. of Total Cost
Dispensed Medicines Month
Expired
Transferred/ Medicines
Beneficiaries Non- Donated
Beneficiaries
n = (k + l + o = h - (k + l
k=i+j m) x f + m)
(i) (j) (k) (l) (m) (n) (o)
3 3 0 97
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
4 4 0 96
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
1 1 0 149
0 0 0
0 0 0
0 0 0
5 5 0 95
0 0 0
0 0 0
0 0 0
72
0 0 0
0 0 0
lidated by:
M
A
I Source of Balance of
Procurement / Last Month
N Health Program Name of Medicines & Description No. of Target
Funds ei. DOH- Patients
T CO/DOH-RO Delivery Date
E
N
A
N
C (a)
E
Amlodipine 10mg, 30 tablets / treatment
M CO 1 pack (TP) 397 1961
E
D
I Losartan 50mg, 30 tablets / treatment
CO 2
pack (TP) 338 1469
C
I
N CO 3 Metoprolol 50mg, 60 tablets / treatment
E pack (TP)
43 0
S
Metformin 500mg, 90 tablets / treatment
A CO 4 pack (TP)
C 64 493
C Simvastatin 40mg, 30 tablets / treatment
E CO 5 pack (TP)
SF 30 70
AS
M CO 6 Gliclazide
PI 10 0
RL
Y
O Combined Oral Contraceptive Pills (COC)
G per cycle - Microgynon
P 934 107
R 1
A L Combined Oral Contraceptive Pills (COC)
A
M per cycle - Femme
N 401 35
N(
M I
N
M
G)
74
P
L
A
N
N Progestin Only Pills (POP) per cycle -
I 2
Excluton
N 171 65
G
Depo medroxyprogesterone acetate
3
(DMPA) vial
P 183 182
R
O 4 Intrauterine Device (IUD)
G 25 14
R
A 5 Male Condoms
from RHU Merida
M 7/11/18
97 45
(
F
P
)
75
Source of Balance of
Procurement / No. of Target Last Month
Health Program Name of Medicines & Description
Funds ei. DOH- Patients
E CO/DOH-RO
Delivery Date
X
P
A
N (a)
D
1 Bivalent Oral Polio Vaccine (BOPV)
E 148 62 7/6/2018
D
2 Inactivated Polio Vaccine (IPV)
42 54 7/6/2018
P
R 3 BCG Vaccine, 20 doses
50 13
O
G 4 Hepatitis B vaccine, 10 doses 10 10
R
A Live attenuated measles, mumps, rubella
5 multidose (MMR) 80 119 7/6/2018
M
6 MR vaccine, 10 doses
F 10 29
O
R 7 DPT-HEPB-HIB vaccine 0.5ml (Penta)
160 338 7/6/2018
I 8 TD vaccine, single dose
50 22 7/6/2018
M
M 9 TD vaccine, 10 doses
0 8
U
N 10 HPV vaccine 4-valent
I 50 88
Z 11 Pneumococcal Conjugate Vaccine
A (PCV 13) 200 354 7/6/2018
T
12 Polysaccharide
I Polyvalent Vaccine (PPV
23) 0 0
O
N 13 Influenza Vaccine
0 0
( Vitamin A 100,000 iu, 100 tablets per
E 1 bottle 50 6
P
I N 2 Vitamin A 200,000 iu, 100 tablets per
) U bottle 50 43
T
R 3 FeSO4 drops 125mg
I 25 53
T 4 Iron tablet with Folic acid, 100 tablets per
I bottle 50 1209
O
Micronutrient powder, sachets
N - Sprinkles 0 0
5
P Micronutrient powder, sachets
R - Vitamix 30 2915
O
G 6 Iodine capsules
R 0 0
A
M 7 Iodine salt test kits
0 0
O 76
G
R
A
M
Source of Balance of
Procurement / No. of Target Last Month
Health Program Name of Medicines & Description
Funds ei. DOH- Patients
CO/DOH-RO
Delivery Date
(a)
Prepared by:
LOVELY LYN P. ANO-OS / IRIS L. EMPASIS
Logistics Coordinator/Medicines Access Program Coordinator
79
Beginning
Stocks of the
Total Month
Total Cost
Discrepancy
Qty. Received
Qty. stated in from Other Actual Qty. Unit (tab,
the Invoice Health Facility Unit Cost
(other than Received amp, cap,
Receipt Expiry Date Lot No.
DOH), if any pcs, pack
e = b - d OR etc.)
g=dxf h=a+c+d
e=c-d
TP 1961
TP 1469
TP 0 0
TP 0 493
TP 0 70
TP 0 0
per cycle 0 35
80
per cycle 0 65
vial 0 182
per device 0 14
10 10 Dec. 2019
P3A49 vial 0 64
vial 0 13
vial 0 10
015M7007 vial
48 48 June 2019 B 0 167
vial
0 29
279X7014E vial
504 504 May 2019 0 842
Sept. 258Q6018
210 210 2019 AE amp 0 232
vial 0 8
vial 0 88
T28217 vial
454 454 June 2020 0 808
vial
0 0
vial 0 0
bottle
0 6
bottle
0 43
bottle
0 53
bottle
0 1209
sachet
0 0
sachet
0 2915
per bottle
0 0
per kit
0 0
82
sachet
0 700
6/25/202 tablet
5040 5040 0 LCT1717 0 5040
vial
0 0
vial
0 0
vial
0 3
bottle
0 351
83
tab 0 97
tab 0 0
tab
0 0
tab
0 0
tab 0 0
tab 0 0
tab 0 96
tab 0 0
tab 0 0
vial 0 0
vial 0 0
amp 0 0
tab 0 0
tab 0 0
amp 0 0
amp
0 0
tab 0 149
tab 0 0
tab 0 0
tab 0 0
tab 0 95
tab
0 0
tab 0 0
tab 0 0
84
cap 0 0
tab 0 0
Number of DOH
Medicines Dispensed
0 0 0 0
32 32 0 461
7 7 0 63
0 0 0 0
64 64 0 43
2 2 0 33
86
38 38 0 27
12 12 0 170
2 2 0 12
4 4 0 761
87
Number of DOH
Medicines Dispensed
Qty. End of the
Qty. of Total Cost
Dispensed Qty. of Month
Medicines
Expired
Transferred/ Medicines
Beneficiaries Non- Donated
Beneficiaries
n = (k + l + o = h - (k + l
k=i+j m) x f + m)
0 0 0 115
10 10 0 54
13 13 0 0
1 1 0 9
35 35 0 132
0 0 0 29
35 35 0 197
8 8 0 0
0 0 0 88
0 0 0 0
0 0 0 0
1 1 0 5
1 1 0 42
13 13 0 40
48 48 0 1161
0 0 0 0
0 0 0 0
0 0 0 0
88
700 700 0 0
0 0 0 0
3 3 0 0
Number of DOH
Medicines Dispensed
Qty. Qty. of End of the
Qty. of Total Cost
Dispensed Medicines Month
Expired
Transferred/ Medicines
Beneficiaries Non- Donated
Beneficiaries
n = (k + l + o = h - (k + l
k=i+j m) x f + m)
(i) (j) (k) (l) (m) (n) (o)
97 97 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
96 96 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
59 59 0 90
0 0 0
0 0 0
0 0 0
35 35 0 60
0 0 0
0 0 0
0 0 0
90
0 0 0
0 0 0
lidated by:
M
A
I Source of Balance of
Procurement / Last Month
N Health Program Name of Medicines & Description No. of Target
Funds ei. DOH- Patients
T CO/DOH-RO Delivery Date
E
N
A
N
C (a)
E
Amlodipine 10mg, 30 tablets / treatment
M CO 1 pack (TP) 397 1720
E
D
I Losartan 50mg, 30 tablets / treatment
CO 2
pack (TP) 338 1276
C
I
N CO 3 Metoprolol 50mg, 60 tablets / treatment
E pack (TP)
43 0
S
Metformin 500mg, 90 tablets / treatment
A CO 4 pack (TP)
C 64 461
C Simvastatin 40mg, 30 tablets / treatment
E CO 5 pack (TP)
S 30 63
SF
A CO 6 Gliclazide
P
M 10 0
RI
O Combined Oral Contraceptive Pills (COC)
L per cycle - Microgynon
G
Y 934 43
R 1
A
P
M L
A
N(
M
N
M I
N)
F
A 92
M
I
L
Y 1
P Combined Oral Contraceptive Pills (COC)
L per cycle - Femme
401 33
A
N Progestin Only Pills (POP) per cycle -
2
N Excluton
171 27
I
N 3 Depo medroxyprogesterone acetate
G (DMPA) vial
183 170
P Progestin Subdermal Implant (Implanon
R 4 NXT)
O 10 0 Jul-18
G
R 5 Intrauterine Device (IUD)
A 25 12
M
6 Male Condoms
( 97 761
F
P
)
93
Source of Balance of
Procurement / No. of Target Last Month
Health Program Name of Medicines & Description
Funds ei. DOH- Patients
E CO/DOH-RO
Delivery Date
X
P
A
N (a)
D
1 Bivalent Oral Polio Vaccine (BOPV)
E 148 115
D
2 Inactivated Polio Vaccine (IPV)
42 54
P
R 3 BCG Vaccine, 20 doses
50 0 8/2/2018
O
G 4 Hepatitis B vaccine, 10 doses 10 9
R
A Live attenuated measles, mumps, rubella
5 multidose (MMR) 80 132
M
6 MR vaccine, 10 doses
F 10 29
O
R 7 DPT-HEPB-HIB vaccine 0.5ml (Penta)
160 665
I 8 TD vaccine, single dose
50 197
M
M 9 TD vaccine, 10 doses
0 0
U
N 10 HPV vaccine 4-valent
I 50 88
Z 11 Pneumococcal Conjugate Vaccine
A (PCV 13) 200 516 8/2/2018
T
12 Polysaccharide
I Polyvalent Vaccine (PPV
23) 0 0
O
N 13 Influenza Vaccine
0 0
( Vitamin A 100,000 iu, 100 tablets per
E 1 bottle 50 5
P
I N 2 Vitamin A 200,000 iu, 100 tablets per
) U bottle 50 42
T
R 3 FeSO4 drops 125mg
I 25 40
T 4 Iron tablet with Folic acid, 100 tablets per
I bottle 50 1161
O
Micronutrient powder, sachets
N - Sprinkles 0 0
5
P Micronutrient powder, sachets
R - Vitamix 30 2795
O
G 6 Iodine capsules
R 0 0
A
M 7 Iodine salt test kits
0 0
O 94
G
R
A
M
Source of Balance of
Procurement / No. of Target Last Month
Health Program Name of Medicines & Description
Funds ei. DOH- Patients
CO/DOH-RO
Delivery Date
(a)
Prepared by:
LOVELY LYN P. ANO-OS / IRIS L. EMPASIS,RN
Logistics Coordinator/Medicines Access Program Coordinator
97
Beginning
Stocks of the
Total Month
Total Cost
Discrepancy
Qty. Received
Qty. stated in from Other Actual Qty. Unit (tab,
the Invoice Health Facility Unit Cost
(other than Received amp, cap,
Receipt Expiry Date Lot No.
DOH), if any pcs, pack
e = b - d OR etc.)
g=dxf h=a+c+d
e=c-d
TP 1720
TP 1276
TP 0 0
TP 0 461
TP 0 63
TP 0 0
per cycle 0 43
98
per cycle 0 33
3/2020
per cycle 0 27
per device 0 12
7/2019
8/6/2018 vial 0 88
T76906 vial
76 76 6/2020 0 592
vial
0 0
vial 0 0
bottle
0 5
bottle
0 42
bottle
0 40
bottle
0 1161
sachet
0 0
sachet
0 2795
per bottle
0 0
per kit
0 0
100
sachet
0 0
6/25/202 tablet
0 0 4520
vial
0 0
vial
0 0
vial
0 0
bottle
0 177
101
tab 0 0
tab 0 0
tab
0 0
tab
0 0
tab 0 0
tab 0 0
tab 0 0
tab 0 0
tab 0 0
vial 0 0
vial 0 0
amp 0 0
tab 0 0
tab 0 0
amp 0 0
amp
0 0
tab 0 90
tab 0 0
tab 0 0
tab 0 0
tab 0 60
tab
0 0
tab 0 0
tab 0 0
102
cap 0 0
tab 0 0
Number of DOH
Medicines Dispensed
0 0 0 0
36 36 0 425
6 6 0 57
0 0 0 0
43 43 0 0
104
5 5 0 28
27 27 0 0
14 14 0 156
21 21 0 109
0 0 0 12
Number of DOH
Medicines Dispensed
Qty.
Qty. of Total Cost End of the Month
Dispensed Qty. of
Medicines
Expired
Transferred/ Medicines
Beneficiaries Non- Donated
Beneficiaries
n = (k + l +
k=i+j o = h - (k + l + m)
m) x f
7 7 0 108
4 4 0 50
1 1 0 9
0 0 0 9
26 26 0 106
0 0 0 29
78 78 0 119
0 0 0 0
11 11 77 0 0
0 0 0 0
0 0 0 0
2 2 0 3
0 0 0 42
40 40 0 0
0 0 0 0
0 0 0 0
0 0 0 0
106
0 0 0 0
0 0 0 4520
0
0 0 0
0 0 0 0
0 0 0 0
155 155 0 22
107
Number of DOH
Medicines Dispensed
Qty. Qty. of Qty. of Total Cost End of the Month
Dispensed Medicines Expired
Transferred/ Medicines
Beneficiaries Non- Donated
Beneficiaries
n = (k + l +
k=i+j o = h - (k + l + m)
m) x f
(i) (j) (k) (l) (m) (n) (o)
0 0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
30 30 0 60
0 0 0
0 0 0
0 0 0
0 0 0 60
0 0 0
0 0 0
0 0 0
108
0 0 0
0 0 0
lidated by:
M
A
I Source of Balance of
Procurement / Last Month
N Health Program Name of Medicines & Description No. of Target
Funds ei. DOH- Patients
T CO/DOH-RO Delivery Date
E
N
A
N
C (a)
E
Amlodipine 10mg, 30 tablets / treatment
M CO 1 pack (TP) 397 1486
E
D
I Losartan 50mg, 30 tablets / treatment
CO 2
pack (TP) 338 1095
C
I
N CO 3 Metoprolol 50mg, 60 tablets / treatment
E pack (TP)
43 0
S
Metformin 500mg, 90 tablets / treatment
A CO 4 pack (TP)
C 64 425
C Simvastatin 40mg, 30 tablets / treatment
E CO 5 pack (TP)
S 30 57
SF
A CO 6 Gliclazide
P
M 10 0
RI
O Combined Oral Contraceptive Pills (COC)
L per cycle - Microgynon
G
Y 934 0
R 1
A
P
M L
A
N(
M
N
M I
N)
F
A 110
M
I
L
Y 1
P Combined Oral Contraceptive Pills (COC)
L per cycle - Femme
401 28
A
N Progestin Only Pills (POP) per cycle -
2
N Excluton
171 0
I
N 3 Depo medroxyprogesterone acetate
G (DMPA) vial
183 156 8/9/2018
P Progestin Subdermal Implant (Implanon
R 4 NXT)
O 10 109
G
R 5 Intrauterine Device (IUD)
A 25 12
M
6 Male Condoms
( 97 610
F
P
)
111
Source of Balance of
Procurement / No. of Target Last Month
Health Program Name of Medicines & Description
Funds ei. DOH- Patients
E CO/DOH-RO
Delivery Date
X
P
A
N (a)
D
1 Bivalent Oral Polio Vaccine (BOPV)
E 148 108
D
2 Inactivated Polio Vaccine (IPV)
42 50
P
R 3 BCG Vaccine, 20 doses
50 9
O
G 4 Hepatitis B vaccine, 10 doses 10 9
R
A Live attenuated measles, mumps, rubella
5 multidose (MMR) 80 106 9/10/2018
M
6 MR vaccine, 10 doses
F 10 29
O
R 7 DPT-HEPB-HIB vaccine 0.5ml (Penta)
160 513
I 8 TD vaccine, single dose
50 119
M
M 9 TD vaccine, 10 doses
0 0 9/10/2018
U
N 10 HPV vaccine 4-valent
I 50 0 9/10/2018
Z 11 Pneumococcal Conjugate Vaccine
A (PCV 13) 200 395
T
12 Polysaccharide
I Polyvalent Vaccine (PPV
23) 0 0
O
N 13 Influenza Vaccine
0 0
( Vitamin A 100,000 iu, 100 tablets per
E 1 bottle 50 3
P
I N 2 Vitamin A 200,000 iu, 100 tablets per
) U bottle 50 42
T
R 3 FeSO4 drops 125mg
I 25 0
T 4 Iron tablet with Folic acid, 100 tablets per
I bottle 150 1030 8/7/2018
O
Micronutrient powder, sachets
N - Sprinkles 0 0
5
P Micronutrient powder, sachets
R - Vitamix 30 2395
O
G 6 Iodine capsules
R 0 0
A
M 7 Iodine salt test kits
0 0
O 112
G
R
A
M
Source of Balance of
Procurement / No. of Target Last Month
Health Program Name of Medicines & Description
Funds ei. DOH- Patients
CO/DOH-RO
Delivery Date
(a)
Prepared by:
LOVELY LYN P. ANO-OS / IRIS L. EMPASIS,RN
Logistics Coordinator/Medicines Access Program Coordinator
115
Beginning
Stocks of the
Total Month
Total Cost
Discrepancy
Qty. Received
Qty. stated in from Other Actual Qty. Unit (tab,
the Invoice Health Facility Unit Cost
(other than Received amp, cap,
Receipt Expiry Date Lot No.
DOH), if any pcs, pack
e = b - d OR etc.)
g=dxf h=a+c+d
e=c-d
TP 1486
TP 1095
TP 0 0
TP 0 425
TP 0 57
TP 0 0
per cycle 0 0
116
per cycle 0 28
per cycle 0 0
7/2020
586005 vial 0 264
8/2020
108 108 585982
per 0 109
device
per device 0 12
vial 0 108
vial 0 50
vial 0 9
vial 0 9
vial
200 200 8/2019 015M7020 0 306
vial
0 29
vial
0 513
amp 0 119
22150021
144 144 1/2020 7B vial 0 144
5/26/201
200 200 9 N021148 vial 0 200
vial
0 395
vial
0 0
vial 0 0
bottle
0 3
bottle
0 42
bottle
0 0
bottle
584 584 4/2019 FSTT-79 0 1614
sachet
0 0
sachet
0 2395
per bottle
0 0
per kit
0 0
118
sachet
0 0
tablet
0 4520
vial
0 0
vial
0 0
vial
19 19 4/2019 GS62C46 0 19
bottle
0 22
119
tab 0 0
tab 0 0
tab
0 0
tab
0 0
tab 0 0
tab 0 0
tab 0 0
tab 0 0
tab 0 0
vial 0 0
vial 0 0
amp 0 0
tab 0 0
tab 0 0
amp 0 0
amp
0 0
tab 0 60
tab 0 0
tab 0 0
tab 0 0
tab 0 60
tab
0 0
tab 0 0
tab 0 0
120
cap 0 0
tab 0 0
Number of DOH
Medicines Dispensed
0 0 0 0
31 31 0 394
2 2 0 55
0 0 0 0
0 0 0 0
122
27 27 0 1
0 0 0 0
26 26 0 238
0 0 0 109
1 1 0 11
Number of DOH
Medicines Dispensed
Qty.
Qty. of Total Cost End of the Month
Dispensed Qty. of
Medicines
Expired
Transferred/ Medicines
Beneficiaries Non- Donated
Beneficiaries
n = (k + l +
k=i+j o = h - (k + l + m)
m) x f
10 10 0 98
5 5 0 45
3 3 0 6
0 0 0 9
17 17 0 12
68 68 0 51
0 0 0 144
0 0 0 200
26 26 0 369
0 0 0 0
0 0 0 0
1 1 0 2
13 13 0 29
0 0 0 0
0 0 0 0
0 0 0 0
0 0 0 0
124
0 0 0 0
0 0 0 0
5 5 0 14
22 22 0 0
125
Number of DOH
Medicines Dispensed
Qty. Qty. of Qty. of Total Cost End of the Month
Dispensed Medicines Expired
Transferred/ Medicines
Beneficiaries Non- Donated
Beneficiaries
n = (k + l +
k=i+j o = h - (k + l + m)
m) x f
(i) (j) (k) (l) (m) (n) (o)
0 0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0 60
0 0 0
0 0 0
0 0 0
0 0 0 60
0 0 0
0 0 0
0 0 0
126
0 0 0
0 0 0
lidated by:
N6017 (8/2018)
128
M
A
I Source of Balance of
Procurement / Last Month
N Health Program Name of Medicines & Description No. of Target
Funds ei. DOH- Patients
T CO/DOH-RO Delivery Date
E
N
A
N
C (a)
E
Amlodipine 10mg, 30 tablets / treatment
M CO 1 pack (TP) 397 1250 10/10/2018
E
D
I Losartan 50mg, 30 tablets / treatment
CO 2
pack (TP) 338 891 10/10/2018
C
I
N CO 3 Metoprolol 50mg, 60 tablets / treatment
E pack (TP)
43 0
S
Metformin 500mg, 90 tablets / treatment
A CO 4 pack (TP)
C 64 394
C Simvastatin 40mg, 30 tablets / treatment
E CO 5 pack (TP)
S 30 55 10/9/2018
SF Gliclazide 30 mg, 30 tablets/ treatment
A CO 6 pack (TP)
P
M 10 0 10/9/2018
RI
O Combined Oral Contraceptive Pills (COC)
L per cycle - Microgynon
G
Y 934 0
R 1
A
P
M L
A
N(
M
N
M I
N)
F
A 129
M
I
L
Y 1
P Combined Oral Contraceptive Pills (COC)
L per cycle - Femme
401 1 9/10/2018
A
N Progestin Only Pills (POP) per cycle -
2
N Excluton
171 0
I
N 3 Depo medroxyprogesterone acetate
G (DMPA) vial
183 238
P Progestin Subdermal Implant (Implanon
R 4 NXT)
O 10 109
G
R 5 Intrauterine Device (IUD)
A 25 11
M
6 Male Condoms 9/10/2018
( 97 433
F
P
)
130
Source of Balance of
Procurement / No. of Target Last Month
Health Program Name of Medicines & Description
Funds ei. DOH- Patients
E CO/DOH-RO
Delivery Date
X
P
A
N (a)
D
1 Bivalent Oral Polio Vaccine (BOPV)
E 148 98
D
2 Inactivated Polio Vaccine (IPV)
42 45
P
R 3 BCG Vaccine, 20 doses
50 6
O
G 4 Hepatitis B vaccine, 10 doses 10 9
R
A Live attenuated measles, mumps, rubella
5 multidose (MMR) 80 230 10/2/2018
M
6 MR vaccine, 10 doses
F 10 12
O
R 7 DPT-HEPB-HIB vaccine 0.5ml (Penta)
160 378
I 8 TD vaccine, single dose
50 51
M
M 9 TD vaccine, 10 doses
0 144
U
N 10 HPV vaccine 4-valent
I 50 200
Z 11 Pneumococcal Conjugate Vaccine
A (PCV 13) 200 369 10/12/2018
T
12 Polysaccharide
I Polyvalent Vaccine (PPV
23) 0 0
O
N 13 Influenza Vaccine
0 0
( Vitamin A 100,000 iu, 100 tablets per
E 1 bottle 50 2
P
I N 2 Vitamin A 200,000 iu, 100 tablets per
) U bottle 50 29
T
R 3 FeSO4 drops 125mg
I 25 0
T 4 Iron tablet with Folic acid, 100 tablets per
I bottle 150 1461
O
Micronutrient powder, sachets
N - Sprinkles 0 0
5
P Micronutrient powder, sachets
R - Vitamix 30 1610
O
G 6 Iodine capsules
R 0 0
A
M 7 Iodine salt test kits
0 0
O 131
G
R
A
M
Source of Balance of
Procurement / No. of Target Last Month
Health Program Name of Medicines & Description
Funds ei. DOH- Patients
CO/DOH-RO
Delivery Date
(a)
Prepared by:
LOVELY LYN P. ANO-OS / IRIS L. EMPASIS,RN
Logistics Coordinator/Medicines Access Program Coordinator
134
Beginning
Stocks of the
Total Month
Total Cost
Discrepancy
Qty. Received
Qty. stated in from Other Actual Qty. Unit (tab,
the Invoice Health Facility Unit Cost
(other than Received amp, cap,
Receipt Expiry Date Lot No.
DOH), if any pcs, pack
e = b - d OR etc.)
g=dxf h=a+c+d
e=c-d
TP 0 0
TP 0 394
TP 2962 100
100 100 1/2020 8A140A 29.62
per cycle 0 0
135
per cycle 0 0
vial 0 238
per 0 109
device
per device 0 11
vial 0 98
vial 0 45
vial 0 6
vial 0 9
vial
400 400 12/2019 015N7025 0 630
vial
0 12
vial
0 378
amp 0 51
vial 0 144
vial 0 200
T76906 vial
100 100 6/2020 0 469
vial
0 0
vial 0 0
bottle
0 2
bottle
0 29
bottle
0 0
bottle
0 1461
sachet
0 0
sachet
0 1610
per bottle
0 0
per kit
0 0
137
sachet
0 0
tablet
0 4420
vial
0 0
vial
0 0
vial
0 14
bottle
0 0
138
tab 0 0
tab 0 0
tab
0 0
tab
0 0
tab 0 0
tab 0 0
tab 0 0
tab 0 0
tab 0 0
vial 0 0
vial 0 0
amp 0 0
tab 0 0
tab 0 0
amp 0 0
amp
0 0
tab 0 60
tab 0 0
tab 0 0
tab 0 0
tab 0 60
tab
0 0
tab 0 0
tab 0 0
139
cap 0 0
tab 0 0
Number of DOH
Medicines Dispensed
0 0 0 0
30 30 0 364
8 8 293.36 147
0 0 0 100
0 0 0 0
141
23 23 0 225
0 0 0 0
13 13 0 225
0 0 0 109
0 0 0 11
70 70 0 459
142
Number of DOH
Medicines Dispensed
Qty.
Qty. of Total Cost End of the Month
Dispensed Qty. of
Medicines
Expired
Transferred/ Medicines
Beneficiaries Non- Donated
Beneficiaries
n = (k + l +
k=i+j o = h - (k + l + m)
m) x f
17 17 0 81
4 4 0 41
3 3 0 3
12 12 0 0
20 20 0 31
40 40 0 104
97 97 0 103
0 0 0 0
0 0 0 0
0 0 0 2
0 0 0 29
0 0 0 0
0 0 0 0
0 0 0 0
0 0 0 0
143
0 0 0 0
0 0 0 4420
0
0 0 0
0 0 0 0
2 2 0 12
0 0 0 0
144
Number of DOH
Medicines Dispensed
Qty. Qty. of Qty. of Total Cost End of the Month
Dispensed Medicines Expired
Transferred/ Medicines
Beneficiaries Non- Donated
Beneficiaries
n = (k + l +
k=i+j o = h - (k + l + m)
m) x f
(i) (j) (k) (l) (m) (n) (o)
0 0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0 60
0 0 0
0 0 0
0 0 0
0 0 0 60
0 0 0
0 0 0
0 0 0
145
0 0 0
0 0 0
lidated by:
l Birthing Center
147
M
A
I Source of Balance of
Procurement / Last Month
N Health Program Name of Medicines & Description No. of Target
Funds ei. DOH- Patients
T CO/DOH-RO Delivery Date
E
N
A
N
C (a)
E
Amlodipine 10mg, 30 tablets / treatment
M CO 1 pack (TP) 397 1250 10/10/2018
E
D
I Losartan 50mg, 30 tablets / treatment
CO 2
pack (TP) 338 891 10/10/2018
C
I
N CO 3 Metoprolol 50mg, 60 tablets / treatment
E pack (TP)
43 0
S
Metformin 500mg, 90 tablets / treatment
A CO 4 pack (TP)
C 64 394
C Simvastatin 40mg, 30 tablets / treatment
E CO 5 pack (TP)
S 30 55 10/9/2018
SF Gliclazide 30 mg, 30 tablets/ treatment
A CO 6 pack (TP)
P
M 10 0 10/9/2018
RI
O Combined Oral Contraceptive Pills (COC)
L per cycle - Microgynon
G
Y 934 0
R 1
A
P
M L
A
N(
M
N
M I
N)
F
A 148
M
I
L
Y 1
P Combined Oral Contraceptive Pills (COC)
L per cycle - Femme
401 225 10/4/2018
A
N Progestin Only Pills (POP) per cycle -
2
N Excluton
171 0 10/4/2018
I
N 3 Depo medroxyprogesterone acetate
G (DMPA) vial
183 225
P Progestin Subdermal Implant (Implanon
R 4 NXT)
O 10 109
G
R 5 Intrauterine Device (IUD)
A 25 11
M
6 Male Condoms
( 97 459
F
P
)
149
Source of Balance of
Procurement / No. of Target Last Month
Health Program Name of Medicines & Description
Funds ei. DOH- Patients
E CO/DOH-RO
Delivery Date
X
P
A
N (a)
D
1 Bivalent Oral Polio Vaccine (BOPV)
E 148 98
D
2 Inactivated Polio Vaccine (IPV)
42 45
P
R 3 BCG Vaccine, 20 doses
50 6
O
G 4 Hepatitis B vaccine, 10 doses 10 9
R
A Live attenuated measles, mumps, rubella
5 multidose (MMR) 80 230 10/2/2018
M
6 MR vaccine, 10 doses
F 10 12
O
R 7 DPT-HEPB-HIB vaccine 0.5ml (Penta)
160 378
I 8 TD vaccine, single dose
50 51
M
M 9 TD vaccine, 10 doses
0 144
U
N 10 HPV vaccine 4-valent
I 50 200
Z 11 Pneumococcal Conjugate Vaccine
A (PCV 13) 200 369 10/12/2018
T
12 Polysaccharide
I Polyvalent Vaccine (PPV
23) 0 0
O
N 13 Influenza Vaccine
0 0
( Vitamin A 100,000 iu, 100 tablets per
E 1 bottle 50 2
P
I N 2 Vitamin A 200,000 iu, 100 tablets per
) U bottle 50 29
T
R 3 FeSO4 drops 125mg
I 25 0
T 4 Iron tablet with Folic acid, 100 tablets per
I bottle 150 1461
O
Micronutrient powder, sachets
N - Sprinkles 0 0
5
P Micronutrient powder, sachets
R - Vitamix 30 1610
O
G 6 Iodine capsules
R 0 0
A
M 7 Iodine salt test kits
0 0
O 150
G
R
A
M
Source of Balance of
Procurement / No. of Target Last Month
Health Program Name of Medicines & Description
Funds ei. DOH- Patients
CO/DOH-RO
Delivery Date
(a)
Prepared by:
LOVELY LYN P. ANO-OS / IRIS L. EMPASIS,RN
Logistics Coordinator/Medicines Access Program Coordinator
153
Beginning
Stocks of the
Total Month
Total Cost
Discrepancy
Qty. Received
Qty. stated in from Other Actual Qty. Unit (tab,
the Invoice Health Facility Unit Cost
(other than Received amp, cap,
Receipt Expiry Date Lot No.
DOH), if any pcs, pack
e = b - d OR etc.)
g=dxf h=a+c+d
e=c-d
TP 0 0
TP 0 394
TP 2962 100
100 100 1/2020 8A140A 29.62
per cycle 0 0
154
per cycle 0 65
65 65 10/2020 246635
vial 0 225
per 0 109
device
per device 0 11
vial 0 98
vial 0 45
vial 0 6
vial 0 9
vial
400 400 12/2019 015N7025 0 630
vial
0 12
vial
0 378
amp 0 51
vial 0 144
vial 0 200
T76906 vial
100 100 6/2020 0 469
vial
0 0
vial 0 0
bottle
0 2
bottle
0 29
bottle
0 0
bottle
0 1461
sachet
0 0
sachet
0 1610
per bottle
0 0
per kit
0 0
156
sachet
0 0
tablet
0 4420
vial
0 0
vial
0 0
vial
0 14
bottle
0 0
157
tab 0 0
tab 0 0
tab
0 0
tab
0 0
tab 0 0
tab 0 0
tab 0 0
tab 0 0
tab 0 0
vial 0 0
vial 0 0
amp 0 0
tab 0 0
tab 0 0
amp 0 0
amp
0 0
tab 0 60
tab 0 0
tab 0 0
tab 0 0
tab 0 60
tab
0 0
tab 0 0
tab 0 0
158
cap 0 0
tab 0 0
Number of DOH
Medicines Dispensed
0 0 0 0
30 30 0 364
8 8 293.36 147
0 0 0 100
0 0 0 0
160
11 11 0 54
4 4 0 221
5 5 0 104
1 1 0 10
33 33 0 426
161
Number of DOH
Medicines Dispensed
Qty.
Qty. of Total Cost End of the Month
Dispensed Qty. of
Medicines
Expired
Transferred/ Medicines
Beneficiaries Non- Donated
Beneficiaries
n = (k + l +
k=i+j o = h - (k + l + m)
m) x f
17 17 0 81
4 4 0 41
3 3 0 3
12 12 0 0
20 20 0 31
40 40 0 104
97 97 0 103
0 0 0 0
0 0 0 0
0 0 0 2
0 0 0 29
0 0 0 0
0 0 0 0
0 0 0 0
0 0 0 0
162
0 0 0 0
0 0 0 4420
0
0 0 0
0 0 0 0
2 2 0 12
0 0 0 0
163
Number of DOH
Medicines Dispensed
Qty. Qty. of Qty. of Total Cost End of the Month
Dispensed Medicines Expired
Transferred/ Medicines
Beneficiaries Non- Donated
Beneficiaries
n = (k + l +
k=i+j o = h - (k + l + m)
m) x f
(i) (j) (k) (l) (m) (n) (o)
0 0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0 60
0 0 0
0 0 0
0 0 0
0 0 0 60
0 0 0
0 0 0
0 0 0
164
0 0 0
0 0 0
lidated by:
l Birthing Center